During the past decade, St. Joseph's Hospital Health Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 18 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Joseph's Hospital Health Center" #1 sponsor was "Abbott Medical Devices" with 8 trials, followed by "Boston Scientific Corporation" with 7 trials sponsored, "Medtronic Vascular" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "National Cancer Institute (NCI)" with 3 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Joseph's Hospital Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator and "Baim Institute for Clinical Research" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "St. Joseph's Hospital Health Center" are "Coronary Artery Disease" (20 trials), "Coronary Disease" (5 trials), "Coronary Artery Stenosis" (4 trials), "Coronary Stenosis" (3 trials) and "Myocardial Ischemia" (3 trials). Many other conditions were trialed in "St. Joseph's Hospital Health Center" in a lesser frequency.

Most popular intervention types in "St. Joseph's Hospital Health Center" are "Device" (25 trials), "Drug" (9 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "XIENCE" (4 trials), "Absorb BVS" (2 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials) and "Resolute Integrity Stent" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Joseph's Hospital Health Center" are 33 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "St. Joseph's Hospital Health Center". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in St. Joseph's Hospital Health Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Joseph's Hospital Health Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 15 trials that are defined as “Not Applicable".

St. Joseph's Hospital Health Center has several departments that took part in Clinical trials: "Institute for Spine Care" - 2 trials